Factor, 2004 - Google Patents
A Potential Oncogenic Activity of Platelet-Derived GrowthFactor, 2004
View PDF- Document ID
- 908350535903128831
- Author
- Factor D
- Publication year
- Publication venue
- CANCER RESEARCH
External Links
Snippet
The platelet-derived growth factor (PDGF) proteins are potent stimulators of cell proliferation/ transformation and play a major role in cell-cell communication. For over two decades, PDGFs were thought to exist as three dimeric polypeptides (the homodimers AA and BB and …
- 230000002246 oncogenic 0 title abstract description 13
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ustach et al. | A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression | |
| Yin et al. | Isolation of a Novel Latent Transforming Growth Factor-β Binding Protein Gene (LTBP-3)(∗) | |
| Jha et al. | Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 | |
| Yao et al. | MSP–RON signalling in cancer: pathogenesis and therapeutic potential | |
| Yi et al. | Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer | |
| Yu et al. | Platelet-derived growth factor signaling and human cancer | |
| Ongusaha et al. | HB-EGF is a potent inducer of tumor growth and angiogenesis | |
| Newton | Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways | |
| Natali et al. | Overexpression of the met/HGF receptor in renal cell carcinomas | |
| Bardeesy et al. | Role of epidermal growth factor receptor signaling in RAS-driven melanoma | |
| Benvenuti et al. | Ron kinase transphosphorylation sustains MET oncogene addiction | |
| KR100681763B1 (en) | Cancer metastasis inhibiting pharmaceutical composition comprising human lipocalin 2 as an active ingredient, cancer metastasis inhibiting method using same | |
| Cao et al. | Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma | |
| ES2489475T3 (en) | MET inhibitors to enhance the effectiveness of radiotherapy | |
| Criswell et al. | Modulation of NFκB activity and E-cadherin by the type III transforming growth factor β receptor regulates cell growth and motility | |
| Pan et al. | Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis | |
| Wu et al. | Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors | |
| Harvey et al. | Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology | |
| Kornmann et al. | IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells | |
| Miyake et al. | Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential | |
| Mincione et al. | EGF and TGF‐β1 Effects on Thyroid Function | |
| US7473561B2 (en) | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer | |
| CA2568806C (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
| Primo et al. | Human endothelial cells expressing polyoma middle T induce tumors | |
| Billings et al. | Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma |